Franz Boas, MD
Vascular & Interventional Radiology · Duarte, CANPI 1487815692
Payments from drug & device makers
What this record shows
Guerbet LLC accounts for 93.4% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $1,855, more than ten times the $154 reported in 2019.
Across 14 payments — averaging $274.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Guerbet LLC$4K
- BTG International Canada Inc.$154
- Boston Scientific$52
- Merit Medical Systems Inc$25
- Cardiva Medical, Inc.$24
Across 2 payments — averaging $78,313 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Guerbet LLC$157K
What the payments were for
- Travel & lodging$2,12355%
- Food & beverage$1,71345%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Guerbet LLC | 10 | $3,583 |
| BTG International Canada Inc. | 1 | $154 |
| Boston Scientific | 1 | $52 |
| Merit Medical Systems Inc | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lipiodol$3,583
- THERASPHERE-BIO$154
How this compares
$3,837 in reported general payments places this provider in the 55th percentile of 504 vascular & interventional radiology providers in California.
See all vascular & interventional radiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Duarte
- John ParkDuarte$86K
- Mahmood RazaviOrange$2.4M
- Keith TerasakiLos Angeles$1.7M
- Bart DolmatchMountain View$1.7M
- Edward LeeLos Angeles$1.4M
- Alexander MisonoNewport Beach$1.3M
- Kevin BurnsOrange$1.1M
- Siddharth PadiaLos Angeles$960K
- Satoshi TateshimaLos Angeles$764K
- Blaise BaxterSan Francisco$757K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.